StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2013 it was 100.0%, against 37.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2013Dec 31, 2013100.0%+63.0
FY2012Dec 31, 201237.0%+341.7
FY2011Dec 31, 2011-304.7%+118.8
FY2010Dec 31, 2010-423.5%–

More CervoMed figures

See a number that looks wrong?